{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:41:05Z","timestamp":1792813265524,"version":"4.5.0"},"reference-count":17,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IDR"],"DOI":"10.2147\/idr.s427836","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T05:20:05Z","timestamp":1695792005000},"page":"6395-6404","source":"Crossref","is-referenced-by-count":3,"title":["The Impact of ESBLs-Positive Escherichia coli\u2019s Resistance to Cefepime and Its Guidance for Clinical Treatment"],"prefix":"10.2147","volume":"Volume 16","author":[{"given":"Qian","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delu","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/phar.1636","volume":"35","author":"Kaye","year":"2015","journal-title":"Pharmacotherapy"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/IDR.S390026","volume":"16","author":"Minghua","year":"2023","journal-title":"Infect Drug Resist"},{"key":"ref3","first-page":"198","volume":"35","author":"Lu","year":"2017","journal-title":"Chin J Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00284-019-01784-8","volume":"77","author":"Emel","year":"2020","journal-title":"Curr Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1007\/s00284-020-02094-0","volume":"77","author":"Matarac\u0131-Kara","year":"2020","journal-title":"Curr Microbiol"},{"key":"ref6","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 28th ed. CLSI; 2018."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/jac\/dkad106","volume":"78","author":"An","year":"2023","journal-title":"J Antimicrob Chemoth"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1089\/mdr.2021.0228","volume":"28","author":"Yang","year":"2022","journal-title":"Microb Drug Resist"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1128\/JCM.02128-16","volume":"55","author":"Brennan-Krohn","year":"2017","journal-title":"J Clin Microbiol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1128\/AAC.44.9.2534-2536.2000","volume":"44","author":"Martinez-Martinez","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","first-page":"1","volume":"10","author":"Edelberto","year":"2021","journal-title":"Antibiotics"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"106762","DOI":"10.1016\/j.ijantimicag.2023.106762","volume":"61","author":"Christopher","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10096-022-04530-4","volume":"42","author":"Melika","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jgar.2019.03.010","volume":"19","author":"Clasen","year":"2019","journal-title":"J Glob Antimicrob Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"16151620","DOI":"10.1128\/AAC.45.6.1615-1620.2001","volume":"45","author":"Aubert","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2147\/IDR.S191462","volume":"12","author":"Li","year":"2019","journal-title":"Infect Drug Resist"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s10096-022-04430-7","volume":"41","author":"Mizrahi","year":"2022","journal-title":"Eur J Clin Microbiol"}],"container-title":["Infection and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=93113","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=93113","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T05:20:16Z","timestamp":1695792016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/the-impact-of-esbls-positive-escherichia-colis-resistance-to-cefepime--peer-reviewed-fulltext-article-IDR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":17,"URL":"https:\/\/doi.org\/10.2147\/idr.s427836","relation":{},"ISSN":["1178-6973"],"issn-type":[{"value":"1178-6973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}